Frontlight ResearchEarly access
CompletedNo phase
taVNS to Reduce PTSD Symptoms in WTC Responders
Key facts
- Who runs it
- Northwell Health
- Where
- Manhasset, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 31 Mar 2022
- Ended
- 15 Feb 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- taVNS
- Record updated
- 3 April 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- being a Queens WTCHP responder who agreed to be contacted to participate in research
- having PTSD as per DSM criteria indicated by the GRDC
- having elevated PTSD symptoms, indicated by a PCL-S93 score > 44 during an annual monitoring visit between 2018-2020
- having a score of 33 or greater on the PCL-594 delivered during the initial phone screen to determine current symptomatology
- meeting diagnostic indication of PTSD using a Clinician-Administered PTSD Scale (CAPS), which is a clinical interview assessment.95
Who cannot take part
- previously implanted electrically active medical devices (e.g., cardiac pacemakers, automatic implantable cardioverter-defibrillators, VNS)
- other major conditions, that in the judgment of the investigators/WTCHP medical staff, would make the participant unsuitable for inclusion or would interfere with the participant participating in or completing the study. these include:; current treatment with psychotropic medication, including tricyclics, antipsychotics, mood stabilizers, bupropion, barbiturates, stimulants, antiepileptics, opioid medications; current diagnosis or history of any clinically significant cardiac, endocrinologic, pulmonary, neurologic, psychiatric, hepatic, renal, hematologic, neurologic, gastrointestinal, or immunologic; history of any of the following cardiovascular conditions: Moderate to severe congestive heart failure (New York Heart Association class III or IV); Recent (within past 6 months) cerebrovascular accident, myocardial infarction, coronary stenting; Uncontrolled hypertension as defined by a confirmed systolic blood pressure > 160 mmHg or diastolic blood pressure > 100 mmHg; history of or active seizure disorder; history of recurrent vasovagal syncope episodes; diagnosis of cancer (other than non-invasive skin cancer or carcinoma in-situ of the cervix) within the 5 years prior to study entry; history of concurrent illness that requires hospitalization within 30 days prior to study entry; have hypertension/hypotension uncontrolled by medication; participation in another investigational trial during the 30 days prior to study entry or during this project
- active disease involving the auricle or ear canal (e.g., otitis media, tinnitus, infection, perforated tympanic membrane, vestibular and/or balance, excessive cerumen production, skin irritation), unwilling to remove a piercing (e.g., daith or tragus), or use a device (e.g., hearing aid, cochlear implant) that would preclude daily use of the earpiece
- history of unilateral or bilateral vagotomy
- being physically/mentally unable to consent and participate
- inability to speak, read, or write in English,
- exhibiting any current psychotic or manic symptoms, active substance dependence, or current suicidal or homicidal intent/plan, as per the standard MINI neuropsychological assessment.96
- Current pregnancy (self-report)
Where in United States
- Feinstein Institutes for Medical ResearchManhasset, United States
About the trial
What the trial wants to find out
This study seeks to conduct a randomized, double-blind pilot study, to determine whether the Transcutaneous Auricular Vagus Nerve Stimulation and study procedure are feasible and acceptable for use with World Trade Center responders with Post Traumatic Stress Disorder.
The 2 groups in the trial
- taVNS TreatmentTreatment being tested
n = 20
Treatment: taVNS
- Sham ComparatorSham treatment, for comparison
n = 10
Treatment: taVNS
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) to Reduce Post Traumatic Stress Disorder (PTSD) Symptoms in World Trade Center (WTC) Responders
- Publications
- Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Posttraumatic Stress Disorder Symptoms in World Trade Center Responders: A Feasibility and Acceptability Study.International journal of environmental research and public health, 2026
- Record updated
- 3 April 2024